Interleukin-1 and Stroke: Biomarker, Harbinger of Damage, and Therapeutic Target

Publisher： Karger

E-ISSN： 1421-9786|32|6|517-527

ISSN： 1015-9770

Source： Cerebrovascular Diseases, Vol.32, Iss.6, 2011-11, pp. : 517-527

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Interleukin-1 as a therapeutic target in systemic-onset juvenile idiopathic arthritis

By Allantaz Florence   Stichweh Dorothee   Pascual Virginia  

Future Rheumatology, Vol. 2, Iss. 3, 2007-06 ,pp. : 305-312

Future Medicine

Access to resources Recommend Favorite

Myogenic Tone as a Therapeutic Target for Ischemic Stroke

By  

Current Vascular Pharmacology, Vol. 12, Iss. 6, 2014-01 ,pp. : 788-800

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-inflammatory strategies in stroke: a potential therapeutic target

By  

Current Vascular Pharmacology, Vol. 14, Iss. 1, 2016-01 ,pp. : 98-105

Bentham Science Publishers

Access to resources Recommend Favorite

Relevance of Interleukin-1 Receptor Antagonist Intron-2 Polymorphism in Ischemic Stroke

By  

Cerebrovascular Diseases, Vol. 15, Iss. 4, 2003-04 ,pp. : 276-281

Karger

Access to resources Recommend Favorite

Plasma Biomarker and Stroke

By  

Cerebrovascular Diseases, Vol. 32, Iss. 4, 2011-10 ,pp. : 406-406

Karger

Access to resources Recommend Favorite